Radiation Oncology Market would grow at a CAGR of +6% during the forecast period 2018 To 2026 according to Analysts at Healthcare Intelligence Markets
Present day clinical trials are investigating drugs in order to constantly improve to discover new advances that sensitize cancer cells to the effects of radiation, making them easier to destroy with radiation therapy. Real-time imaging is one of the key developments made in the field of oncology that helps to precisely target the radiation beams, while limiting damage to important adjacent organs. Cancer is already the leading cause of total death burden in Australia and North America. With ageing populations in these regions, who are more likely to develop cancer, this problem is anticipated to only increase.
The growing research and development activities done is increasing demand for photon therapy and has been identified as a key trend therefore growing the adoption of radio therapy in the oncology market.
For Sample Copy of this report: https://www.healthcareintelligencemarkets.com/request_sample.php?id=29014
The global radiation oncology market is segmented by application into prostrate and breast cancer. The report grants extensive insights into the changes in legislations and reimbursement policies in the medical field over the last several years. It also features the driving factors influencing the market’s growth, key trends, opportunities and major pitfalls. North American region held the highest market share
The competitive analysis done describes that the market is composed of several number of key players. Some of the prominent competitors include Varian Medical Systems, Inc., Elekta AB, IBA (Ion Beam Applications Sa), Nordion Inc., Accuray Incorporated, C. R. Bard, Inc., and Isoray Medical, Inc. amongst others. Accuray Incorporated have explored some many ways to deliver wide range of solutions to people. They have come up with IMRT with TomoHelical and 3DCRT with TomoDirect for treating breast cancer. Their other treatment solutions include SBRT with CyberKnife to treat prostate and lung cancer.
Increasing geriatric population all over the world is driving the demand for this market. The high cost of these therapies and the side effects of these radiation is hampering the market’s growth. Many hospitals are expected to replace their installed base equipment with photon therapies, which is expected to drive the growth of the market during the forecast period.
Avail Discount on This report : https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=29014
Radiation Oncology Market – By Technology
• Systemic Radiotherapy
Radiation Oncology Market – By Application
• Breast Cancer
Radiation Oncology Market – By Region
• North America
• Rest of North America
• The UK
• Rest of Europe
• Asia Pacific
• Southeast Asia
• Rest of Asia Pacific
• Middle East and Africa
• GCC Countries
• Southern Africa
• Rest of Middle East and Africa
• Latin America
• Rest of Latin America
Radiation oncology market report provides both qualitative and quantitative study of the global market. It also provides noteworthy insights into the rational scenario and favored development methods adopted by the key players. The report also offers extensive research on the major participants and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarter, competitors, product/service type, application and specification, pricing, and gross margin.